The Latest Cardiac and Vascular News
MONTREAL–(BUSINESS WIRE)–Soundbite announces FDA 510(k) Approval for SoundBite® Crossing System – Peripheral (SCS-P) with the 0.014” Active Wire (14P). The SoundBite® Crossing System – Peripheral (14P) is a recanalization tool, designed to help physician’s placement of conventional guidewires or treatment devices in the intraluminal space beyond chronic total occlusions (CTOs) in […]
EchoNous announces new Kosmos Universal Platform (UP) for POCUS educators, an automated AI-driven platform for POCUS QA, credentialing and research REDMOND, Wash.–(BUSINESS WIRE)–Today, EchoNous announced the launch of Kosmos Universal Platform (UP), a specialized software platform that helps educators streamline and automate the process of teaching POCUS, specifically ultrasound scanning—an emerging […]
The new fund will invest in disruptive technologies to streamline healthcare delivery and improve patient outcomes ST PETER PORT, Guernsey & GENEVA & MINNEAPOLIS–(BUSINESS WIRE)–Endeavour Vision today announces the closing of Endeavour Medtech Growth II (EMG II) LP at USD 375 million in capital commitments. The fund will pursue the […]
Patient Enrollment to Begin Within Three Months FREMONT, Calif. and OXFORD, United Kingdom, April 21, 2021 /PRNewswire/ — Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application to conduct a U.S. trial for the Contour […]
First Patient Receives New Shield Surface Modification, An Advance in Flow Diversion Therapy, at NYU Langone Health DUBLIN, April 21, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug Administration (FDA) for Pipeline™ Flex Embolization Device […]
In a first-of-its-kind study, Vesalius proves that its catheter-based anchoring to the papillary muscle is safe and durable VANCOUVER, BC, April 21, 2021 /PRNewswire/ — Vesalius Cardiovascular Inc. (VCI), a Canadian MedTech company developing a Transfemoral Mitral Valve Repair (TMVr) solution, announced today the achievement of a new pre-clinical milestone with its 180-day […]
PARIS, April 21, 2021 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly targets the brain to treat difficult-to-treat and resistant hypertension and heart failure, will present top-line results from its QUORUM study of firibastat in heart […]
Commercial Launch Follows Successful Beta Testing of Prevencio’s Highly Accurate AI-driven HART Tests KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc. today announces an Agreement with Atlas Genomics to commercially launch its highly accurate, AI-driven HART blood tests for heart disease and risk of heart attack, stroke, and cardiovascular death. The HART blood tests are […]
DENVER–(BUSINESS WIRE)–enlightenVue, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for expanded claims for vascular diagnostic and therapeutic applications of its SurgiVue™ single-use micro-endoscope platform. The Notice of Allowance builds on a patent issued in June 2020 covering vascular applications. […]
BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has appointed Shawn Stetson as the Company’s interim chief financial officer, effective May 11, 2021. Mr. Stetson will assume his new responsibilities upon the departure of […]
